EurekAlert!

C-Path’s TRxA announces $1 million award for drug development project in type 1 diabetes

TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B.
EurekAlert!

C-Path’s translational therapeutics accelerator announces new grant award for drug development project in type 1 diabetes

TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment ...
PR Newswire

C-Path's Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub

AMSTERDAM, Oct. 16, 2025 /PRNewswire/ -- Critical Path Institute ® (C-Path) today announced the official launch of the Critical Path Disease Modeling Coalition (CP-DMC) on pediatric inflammatory bowel ...
News Medical

C-Path and Vivpro join forces to advance drug development

Critical Path Institute (C-Path), a leading global nonprofit committed to expediting drug development through the acceleration of regulatory-endorsed solutions, today announced a newly formalized ...